Pusan National University researchers develop self-protecting nanoparticles for effective treatment of colorectal cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 13-Jul-2025 06:11 ET (13-Jul-2025 10:11 GMT/UTC)
Systemic circulation of chemotherapy drugs leads to off-target side effects, premature drug loss, and limited therapeutic efficiency in colorectal cancer (CRC) treatment. Researchers have now developed a drug delivery strategy in which CRC cell-activated nanoconjugates (CTNCs) are enclosed inside a pH-sensitive alginate matrix. This matrix provides a shield against the acidic environment of the stomach and small intestine, ensuring selective drug delivery in the colorectum, thus facilitating precise local CRC therapy without off-target side effects.
The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering technique developed by researchers at UCL and the Francis Crick Institute.
In a landmark review published in Brain Medicine, Professor Hyman M. Schipper maps out the complex interactions between reproductive hormones and neurological health. This comprehensive analysis examines how sex hormones influence various conditions including migraine, stroke, movement disorders, epilepsy, and multiple sclerosis. The review highlights emerging evidence on neurosteroid pathways and suggests potential therapeutic applications, while emphasizing the importance of considering hormonal factors in neurological care.
University of Chicago researchers analyzed data to identify trends that could shed light on why Black women with triple-negative breast cancer (TNBC) have worse survival rates. Since new immunotherapy treatments for metastatic and early-stage TNBC were approved in 2019 and 2021, Howard and Freeman also examined disparities in access to these new treatments. While they found that much of the inequality they observed between racial and ethnic groups could be explained by socioeconomic disparities, they also found that Black women with TNBC were less likely to receive immunotherapy treatment even when accounting for those factors.